https://www.prnewswire.com/news-releases/pelage-pharmaceuticals-advances-clinical-program-with-first-patients-dosed-in-phase-2-study-for-hair-loss-and-gv-led-14m-series-a-1-302220301.html
New stuff. It targets hair follicle stem cells directly via a very crucial pathway.
Still not a bust. Thats what we all tend to think after a first reading but they are doing a long term trial.
We shouldnt completely rule it out until we have the data of the year long trial they started last july.
From Kintor's website: "A total of 270 male and female Androgenetic Alopecia patients will be...
Its quite possible the strong shedding being caused by the change of providers, especially if the new supplier is giving you another generic brand.
Maybe you should research if low dose oral minoxidil (2.5- 5 mg) fits your situation. Talk to a doctor first, while uncommon side effects are real...
Because unless you are an hyper-responder you wont get enough regrowth with that. Most people here need to recover a couple of NWs. And with RU you are not degrading the receptor, just blocking it.
Was expecting more than 10 hairs per cm2. But we all knew this stuff is mainly for maintenance.
For those starting to bald dutasteride/KX combo will be a killer for hairloss prevention
Follica was a "new product": minoxidil + Microneedling. Thats an effective combo coming from Cots and cia research.
The problem: it was already cheap and OTC.
It takes a few days to regenerate though. If this stuff is potent enough and safe it can be the perfect replacement to ARIs like finasteride/dutasteride and AR blockers of course
While its good news this drug is far from being available worldwide, like 3-5 years at least.
Im a bit worried about Kintor, their stock have been falling steadily for the last few months. Most likely because they spent millions on multiple clinical trials for drugs like Proxalutamide for...